How Does Avastin 400mg Injection Work?
Avastin 400mg Injection, containing bevacizumab, works by targeting a protein called vascular endothelial growth factor (VEGF). VEGF plays a key role in the formation of new blood vessels (angiogenesis) that supply oxygen and nutrients to tumors. By blocking this protein, Avastin helps to slow or stop the growth of cancer cells.
Mechanism of Action:
Inhibiting Tumor Blood Supply:
Avastin binds to VEGF and prevents it from interacting with its receptors on blood vessel cells.
This action reduces the formation of new blood vessels that feed the tumor, effectively starving it of nutrients and oxygen needed for growth.
Slowing Tumor Growth:
Without adequate blood supply, the tumor’s ability to grow and spread (metastasize) is significantly reduced.
Enhancing Chemotherapy Effectiveness:
By normalizing blood vessels around the tumor, Avastin improves the delivery of chemotherapy drugs to cancer cells, enhancing treatment efficacy.
How Should You Take Avastin 400mg Injection?
Avastin 400mg Injection is administered as an intravenous infusion by a healthcare professional in a clinical setting. You should never attempt to self-administer this medication.
Key Guidelines for Taking Avastin 400mg Injection:
The injection is given directly into your vein (intravenous infusion).
The first infusion typically lasts about 90 minutes. If you tolerate it well, subsequent infusions may be reduced to 30–60 minutes.
Avastin is often used in combination with chemotherapy or other cancer treatments. The schedule and duration will align with your overall treatment plan.
Your doctor may monitor you for side effects during and after the infusion.
If you experience symptoms like high blood pressure, bleeding, or allergic reactions, inform your medical team immediately.
Mood Stabilization in Bipolar Disorder:
Tegral regulates neurotransmitters like dopamine and glutamate, which play a role in mood stability. This helps you manage manic and mixed episodes effectively.
Reviews
Clear filtersThere are no reviews yet.